1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development of a 3D organotypic explant platform to study oncolytic virus treatment response in glioblastoma
    Meeting Abstract

    Abou-Mrad, Z.; Yu, K.; Tabar, V.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • RRAS and RRAS2 mutations are oncogenic drivers in lung cancer and are sensitive to the PAN-RAS inhibitor RMC-6236
    Meeting Abstract

    Pfeil, A. J.; Zhang, T.; Febres-Aldana, C. A.; Cheng, R.; Mattar, M. S.; Arbour, K.; Ladanyi, M.; Yang, S. R.; Somwar, R.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Integrin-linked kinase facilitates drug tolerant persister cell survival and EMT in response to EGFR targeted therapy
    Meeting Abstract

    Shi, R.; Farnsworth, D.; Atwal, T.; Chow, J.; Sheena, R.; Lee, C. M.; Inoue, Y.; Awrey, S.; McDonald, P.; Somwar, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Comprehensive pan-cancer analysis of oncogenic MET rearrangements with a focus on targetability in NSCLC
    Meeting Abstract

    Vojnic, M.; Febres-Aldana, C. A.; Odintsov, I.; Zhang, T.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A.; Gili, L.; Harshan, M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Lurbinectedin synergizes with selinexor by inhibiting DNA damage repair and enhancing immune cell infiltration in neuroendocrine lung tumors
    Meeting Abstract

    Redin, E.; Manoj, P.; Qiu, J.; Zhong, H.; Vural, S.; Zhan, Y.; Koche, R.; Socci, N.; DeStanchina, E.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • SMARCA4 controls state plasticity in SCLC through regulation of neuroendocrine transcription factors and REST splicing
    Meeting Abstract

    Redin, E.; Sridhar, H.; Zhan, Y.; Pereira Mello, B.; Zhong, H.; Manoj, P.; Linkov, I.; Qiu, J.; Koche, R. P.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • [225Ac]Ac-Isatuximab for CD38-targeted theranostics in a preclinical model of disseminated multiple myeloma
    Meeting Abstract

    Herrero Alvarez, N.; Bauer, D.; Michel, A.; Lewis, J.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • 177Lu/225Ac pretargeted dual-isotope therapy for treatment of GPA33(+) colorectal cancer
    Meeting Abstract

    Rinne, S. S.; Vaughn, B.; Guo, H. F.; Vargas, D. B.; Salehi, N.; Xu, H.; Veach, D.; Vanpouille-Box, C.; Miller, B.; Larson, S.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Dose escalation and curative therapy of colorectal cancer with anti-GPA33 self-assembling and disassembling (SADA) actinium-225 alpha pretargeted radioimmunotherapy
    Meeting Abstract

    Aguirre, N.; Veach, D.; Guo, H. F.; Espinosa-Cotton, M.; Fung, E.; Xu, H.; Feng, Y.; Leung, K.; Cheung, I.; Carrasco, S.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save